LILLE
My previous professional experiences can be resumed at two types of missions: on the bench side and on the strategic marketing side.
On bench side, I have experience in preclinical PK and PD studies both in vitro and in vivo applied in oncology research. I applied and improved techniques ranging from cellular and molecular biology to biochemical techniques.
On the business and strategic marketing side, I was in charge (in close interaction with my clients) with analysis of different qualitative and quantitative aspects like: technology positioning (3D cell based assay, microfluidic) according to the industrial demands; strategy proposal for R&D and business development in line with regulatory constraints specific for different therapeutic (oncology, neuroscience, diabetes, (stem) cell therapy etc) and geographical areas; precise evaluation of the global burden of the diagnosis on health system; market forecasting of the diagnosis tool for 5 years for four cancer types (breast, colorectal, prostate and lung); annual and total volume market evaluations (and forecasting) using epidemiological and field analysis etc.
